Most upside (3 months)

The Most Upside chart above shows the companies potential share price gain (%) (the potential share price increase from the current share to the broker target price)

  Company % change  
  Carillion PLC 310.42  
  Connect Group PLC 71.69  
  Pets At Home Group Plc 70.56  
  The Gym Group Plc 57.07  
  Pendragon PLC 53.33  
  Greencore Group PLC 53.11  
  Lookers PLC 49.12  
  DFS Furniture Plc 47.79  
  Domino's Pizza Group PLC 43.27  
  Low & Bonar PLC 42.68  
  Marston's PLC 41.55  
  Benchmark Holdings Plc 36.75  
  RPC Group PLC 35.36  
  Ladbrokes Coral Group Plc 35.14  
  Servelec Group 32.99  

Performance Analysis (6 Months)

The performance analysis chart above provides a detailed breakdown of Buy, Sell and Hold recommendations for the selected bank or stockbroker. To see a full explanation of how to use this chart, please visit the performance analysis explanation page.

Recommendation Summary (3 months)

Berenberg News

  • Berenberg downgrades NCC

    24 July 2017 | NCC Group
    Berenberg has moved to a sell rating (from hold) on cyber security and risk mitigation services provider NCC Group (LON:NCC), believing the restructuring has now been priced in. The bank...
  • HSBC downgraded by Berenberg

    04 July 2017 | HSBC Holdings
    Berenberg has downgraded its investment rating on banking group HSBC (LON:HSBA) to hold from buy, believing the stock is now fully valued. Nevertheless, analyst James Chappell commented: "HSBC is...
  • GlaxoSmithKline upgraded by Berenberg

    26 May 2017 | GlaxoSmithKline
    Berenberg has upgraded its recommendation on GlaxoSmithKline (LON:GSK) believing long-term value is emerging and that risks are now skewed to the upside at a group level, despite its HIV business,...
  • Broker views: Pharma and mining

    19 May 2017 | Shire
    Equity analysts at HSBC have downgraded their investment rating on Shire Pharmaceuticals (LON:SHP) to 'reduce' (from 'hold'), despite the company reporting positive data from the HELP study...
  • UDG downgraded by Berenberg

    08 May 2017 | UDG Healthcare
    Berenberg Bank has downgraded its investment rating on UDG Healthcare (LON:UDG) to hold (from buy), saying that the shares now looks fully valued. The broker said: "We still believe that UDG is a...

Berenberg Notes